Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Nucleoside Derivatives - Phosphorus-containing nucleosides; 2’-Modified nucleosides; 5’-Modified nucleosides
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | 5 days | Inquiry | |
10 mg | 5 days | Inquiry | |
25 mg | 5 days | Inquiry | |
50 mg | 5 days | Inquiry | |
100 mg | 5 days | Inquiry | |
500 mg | 5 days | Inquiry |
Description | Nucleoside Derivatives - Phosphorus-containing nucleosides; 2’-Modified nucleosides; 5’-Modified nucleosides |
Molecular Weight | N/A |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
1-[6-(Diethoxyphosphinyl)-2-O-(2-methoxyethyl)-β-D-ribo-hexofuranosyl]uracil Others inhibitor inhibit